NextTrip (NTRP) 10-Q 5 Aug 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 04, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-38015
Entity Registrant Name	SIGMA LABS, INC.
Entity Central Index Key	0000788611
Entity Tax Identification Number	27-1865814
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3900 Paseo del Sol
Entity Address, City or Town	Santa Fe
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	87507
City Area Code	(505)
Local Phone Number	438-2576
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SASI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,498,802

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 6,933,499	$ 11,447,047
Accounts Receivable, net	291,758	412,192
Inventory	783,666	710,080
Prepaid Assets	131,475	114,278
Total Current Assets	8,140,398	12,683,597
Other Assets:
Property and Equipment, net	265,678	232,282
Intangible Assets, net	1,029,315	925,111
Total Other Assets	1,294,993	1,157,393
TOTAL ASSETS	9,435,391	13,840,990
Current Liabilities:
Accounts Payable	240,400	206,442
Deferred Revenue	130,704	148,855
Accrued Expenses	253,754	625,942
Total Current Liabilities	624,858	981,239
TOTAL LIABILITIES	624,858	981,239
Stockholders’ Equity
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 465 shares issued and outstanding	1	1
Common Stock, $0.001 par value; 24,000,000 shares authorized; 10,498,802 shares issued and outstanding	10,499	10,499
Additional Paid-In Capital	53,876,218	53,442,431
Accumulated Deficit	(45,076,185)	(40,593,180)
Total Stockholders’ Equity	8,810,533	12,859,751
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 9,435,391	$ 13,840,990

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	465	465
Preferred stock, shares outstanding	465	465
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	24,000,000	24,000,000
Common stock, shares issued	10,498,802	10,498,802
Common stock, shares outstanding	10,498,802	10,498,802

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
REVENUES	$ 236,660	$ 144,148	$ 288,504	$ 602,288
COST OF REVENUE	193,075	116,397	233,166	244,728
GROSS PROFIT	43,585	27,751	55,338	357,560
OPERATING EXPENSES:
Salaries & Benefits	1,184,818	985,348	2,476,828	1,832,520
Stock-Based Compensation	167,439	116,441	338,415	233,919
Operations and R&D Costs	146,885	280,700	290,303	477,040
Investor, Public Relations and Marketing	152,300	114,762	246,626	223,103
Organization Costs	60,817	158,529	119,566	236,145
Legal & Professional Service Fees	144,528	244,019	355,944	420,866
Office Expenses	303,600	151,871	509,032	300,096
Depreciation & Amortization	29,861	25,783	61,445	48,814
Other Operating Expenses	89,177	91,198	176,964	177,554
Total Operating Expenses	2,279,425	2,168,651	4,575,123	3,950,057
LOSS FROM OPERATIONS	(2,235,840)	(2,140,900)	(4,519,785)	(3,592,497)
OTHER INCOME (EXPENSE)
Interest Income	1,176	7,018	2,747	7,073
Gain on Derivative Liability		290,156		1,092,441
State Incentives			76,628
Exchange Rate Gain (Loss)	(10,436)	208	(10,766)	158
Interest Expense	(2,070)	(2,029)	(3,389)	(3,382)
Total Other Income (Expense)	(11,330)	295,353	65,220	1,096,290
LOSS BEFORE PROVISION FOR INCOME TAXES	(2,247,170)	(1,845,547)	(4,454,565)	(2,496,207)
Provision for income Taxes
Net Loss	(2,247,170)	(1,845,547)	(4,454,565)	(2,496,207)
Preferred Dividends	(14,220)	(14,220)	(28,440)	(75,127)
Net Loss Applicable to Common Stockholders	$ (2,261,390)	$ (1,859,767)	$ (4,483,005)	$ (2,571,334)
Net Loss per Common Share – Basic and Diluted	$ (0.22)	$ (0.18)	$ (0.43)	$ (0.28)
Weighted Average Number of Shares Outstanding – Basic and Diluted	10,498,802	10,493,598	10,498,802	9,149,328

Statement of Stockholders' Equi

Statement of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 1	$ 5,995	$ 38,262,744	$ (33,105,008)	$ 5,163,732
Begining balance, shares at Dec. 31, 2020	715	5,995,320
Net Loss				(2,496,207)	(2,496,207)
Preferred Stock Dividends		19	75,108	(75,127)
Stock Options Awarded to Directors			122,274		122,274
Stock Options Awarded to Employees			233,919		233,919
Extinguishment of Derivative Liability			(1,092,441)		(1,092,441)
Common Shares Sold in Public Offerings		$ 3,902	14,865,997		14,869,899
Common Shares Sold in Public Offerings, shares		3,901,783
Preferred Stock Dividends, shares		19,000
Common Shares Issued Upon Conversion of Preferred Shares		$ 100	(100)
Common Shares Issued Upon Conversion of Preferred Shares, shares	(250)	100,000
Common Shares Issued Upon Exercise of Warrants		$ 476	1,135,534		1,136,010
Common Shares Issued Upon Exercise of Warrants, shares		475,995
Securities Issued for Third Party Services		$ 2	55,935		55,937
Securities Issued for Third Party Services, shares		1,500
Offering Costs			(1,600,967)		(1,600,967)
Ending balance, value at Jun. 30, 2021	$ 1	$ 10,494	52,058,003	(35,676,342)	16,392,156
Ending balance, shares at Jun. 30, 2021	465	10,493,598
Beginning balance, value at Mar. 31, 2021	$ 1	$ 10,494	47,225,812	(33,816,575)	13,419,732
Begining balance, shares at Mar. 31, 2021	465	10,493,598
Net Loss				(1,845,547)	(1,845,547)
Preferred Stock Dividends			14,220	(14,220)
Stock Options Awarded to Directors			60,803		60,803
Stock Options Awarded to Employees			116,441		116,441
Extinguishment of Derivative Liability			4,615,771		4,615,771
Securities Issued for Third Party Services			24,956		24,956
Ending balance, value at Jun. 30, 2021	$ 1	$ 10,494	52,058,003	(35,676,342)	16,392,156
Ending balance, shares at Jun. 30, 2021	465	10,493,598
Beginning balance, value at Dec. 31, 2021	$ 1	$ 10,499	53,442,431	(40,593,180)	12,859,751
Begining balance, shares at Dec. 31, 2021	465	10,498,802
Net Loss				(4,454,565)	(4,454,565)
Preferred Stock Dividends			28,440	(28,440)
Stock Options Issued for Third Party Services			23,490		23,490
Stock Options Awarded to Directors			43,442		43,442
Stock Options Awarded to Employees			338,415		338,415
Ending balance, value at Jun. 30, 2022	$ 1	$ 10,499	53,876,218	(45,076,185)	8,810,533
Ending balance, shares at Jun. 30, 2022	465	10,498,802
Beginning balance, value at Mar. 31, 2022	$ 1	$ 10,499	53,661,061	(42,814,795)	10,856,766
Begining balance, shares at Mar. 31, 2022	465	10,498,802
Net Loss				(2,247,170)	(2,247,170)
Preferred Stock Dividends			14,220	(14,220)
Stock Options Issued for Third Party Services			11,777		11,777
Stock Options Awarded to Directors			21,721		21,721
Stock Options Awarded to Employees			167,439		167,439
Ending balance, value at Jun. 30, 2022	$ 1	$ 10,499	$ 53,876,218	$ (45,076,185)	$ 8,810,533
Ending balance, shares at Jun. 30, 2022	465	10,498,802

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
OPERATING ACTIVITIES
Net Loss	$ (4,454,565)	$ (2,496,207)
Noncash Expenses:
Depreciation and Amortization	61,445	48,814
Gain on Derivative Liability		(1,092,441)
Stock Based Compensation - Employees	338,415	233,919
Stock Based Compensation - Third Party Services	23,490	55,937
Stock Based Compensation - Directors	43,442	122,274
Change in assets and liabilities:
Accounts Receivable	120,434	(57,888)
Inventory	(73,586)	(187,348)
Prepaid Assets	(17,197)	(51,591)
Accounts Payable	33,958	186,831
Deferred Revenue	(18,151)	(14,388)
Accrued Expenses	(372,188)	(14,531)
NET CASH USED IN OPERATING ACTIVITIES	(4,314,503)	(3,266,620)
INVESTING ACTIVITIES
Purchase of Property and Equipment	(83,848)	(52,931)
Purchase of Intangible Assets	(115,197)	(55,090)
NET CASH USED IN INVESTING ACTIVITIES	(199,045)	(108,021)
FINANCING ACTIVITIES
Gross Proceeds from Public and Private Issuances of Securities		14,869,899
Less Offering Costs		(1,600,967)
Proceeds from Exercise of Warrants		1,136,010
NET CASH PROVIDED BY FINANCING ACTIVITIES		14,404,942
NET CHANGE IN CASH FOR PERIOD	(4,513,548)	11,030,301
CASH AT BEGINNING OF PERIOD	11,447,047	3,700,814
CASH AT END OF PERIOD	6,933,499	14,731,115
Noncash investing and financing activities disclosure:
Issuance of Common Shares for Preferred Dividends		75,108
Other noncash operating activities disclosure:
Issuance of Securities for services	66,932	178,209
Disclosure of cash paid for:
Interest	3,389	3,382
Income Taxes

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 1 - Summary of Significant Accounting Policies Nature of Business Basis of Presentation Reclassification Fair Value of Financial Instruments The Company does not use derivative instruments for hedging of market risk or for trading or speculative purposes. On March 26, 2021, the Company issued warrants to purchase an aggregate of 2,190,000 May 24, 2021 12,000,000 24,000,000 May 24, 2023 Pursuant to ASC 815-40-25-10, because the Company did not have sufficient authorized and unissued shares of common stock available to settle the warrants at the issue date, such warrants were accounted for as a derivative liability. For the six months ended June 30, 2021, the Company recorded a gain of $ 1,092,441 Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share June 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,528,637 853,936 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,503,336 4,966,350 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended June 30, 2022 and 2021: Schedule of Computing Loss Per Share 1 2 3 4 Three Months Ended June 30 Six Months Ended June 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.18 ) $ (0.43 ) $ (0.28 ) Loss Applicable to Common Stockholders (numerator) $ (2,261,390 ) $ (1,859,767 ) $ (4,483,005 ) $ (2,571,334 ) Weighted average number of common shares outstanding used in loss per share during the period (denominator) 10,498,802 10,493,598 10,498,802 9,149,328 Accounting Estimates Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers, pursuant to which it enters into agreements to lease its PrintRite3D platform for terms between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment that customers have the right to substantially all the economic benefit from and exclusive right to use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The agreements may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months with 30-days written notice. Some, but not all, of the arrangements provide for a lessee to purchase the asset at a stated amount that approximates fair value and are not reasonably certain to be exercised at the inception of the arrangement. There are no anticipated variable lease payments at the inception of the arrangement. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training. The Company has elected the single component practical expedient to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training do not have the same pattern of transfer; therefore, this component is not eligible for the single component practical expedient. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased assets based on the life of the underlying assets, the ability to refurbish and sell the assets, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from lease payments related to these operating leases for the three and six months ended June 30, 2022 was $ 14,138 20,138 Minimum Lease Payments Receivable Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 18,000 2023 $ 3,000 2024 - 2025 and thereafter - Total $ 21,000 Assets Underlying Operating Leases: Assets under operating leases are comprised of the following: Schedule of Assets underlying operating leases June 30, 2022 PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 2,782 Net Book Value $ 36,167 The Company is depreciating assets over their useful life of 7

Inventory

Inventory	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory	NOTE 2 – Inventory At June 30, 2022 and December 31, 2021, the Company’s inventory was comprised of: Schedule of Inventory June 30, 2022 December 31, 2021 Raw Materials $ 172,863 $ 202,015 Work in Process 328,720 224,079 Finished Goods 282,083 283,986 Total Inventory $ 783,666 $ 710,080

Deferral of Social Security Tax

Deferral of Social Security Tax Payments	6 Months Ended
	Jun. 30, 2022
Deferral Of Social Security Tax Payments
Deferral of Social Security Tax Payments	NOTE 3 – Deferral of Social Security Tax Payments Pursuant to sections 2302(a)(1) and (a)(2) of the CARES Act, the Company has elected to defer payments of its share of Social Security tax due during the “payroll tax deferral period.” The payroll tax deferral period began on March 27, 2020 and ended on December 31, 2020. At June 30, 2022, the total remaining amount of the deferral was $ 37,728 December 31, 2022 0

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Stockholders’ Equity	NOTE 4 - Stockholders’ Equity Common Stock On May 24, 2021, at a Special Stockholders Meeting, our stockholders approved an increase in the authorized shares of common stock from 12,000,000 24,000,000 In January 2021, the Company closed a public offering of its securities in which it issued 1,711,783 3.00 4,532,445 136,943 3.75 In February 2021, the Company issued 263,200 In March 2021, the Company issued 119,000 250 19,000 191,204 21,591 In March 2021, the Company closed a public offering in which it issued 2,190,000 4.445 8,736,487 12,000,000 24,000,000 2,190,000 4.32 May 24, 2021 175,200 8 125 5.55625 8 In March 2021, Company issued 1,500 4.99 Preferred Stock The Company is authorized to issue 10,000,000 0.001 465 In January 2020, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain institutional investors (the “Institutional Private Placement”). Pursuant to the SPA, the Company issued and sold 1,640 1,000 9 2.50 Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed. At June 30, 2022, there were 132 87,267 Concurrent with the Institutional Private Placement, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued and sold to certain of its directors and the Company’s largest shareholder 333 1,000 9 48,544 At June 30, 2022, 333 61,651 Stock Options As of June 30, 2022, an aggregate of 201,861 In March 2022, the Company granted options to its non-employee directors to purchase up to an aggregate of 56,000 2.50 50 50 During the six months ended June 30, 2022, the Company granted four employees options to purchase up to an aggregate of 22,000 2.50 70,000 2.50 Also in March 2022, the Company granted two consultants options to purchase up to an aggregate of 14,000 2.50 The Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company’s stock on the grant date. Stock options are typically granted throughout the year and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified. The Company recognizes compensation expense for the fair value of the stock options over the requisite service period for each stock option award. Total stock-based compensation expense included in the statements of operations for the six months ended June 30, 2022 and 2021 was $ 338,415 233,919 The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the six months ended June 30, 2022 and 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions Assumptions: 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.95 1.65 % 0.19 0.32 % Expected volatility 106.4 110.0 % 116.8 123.8 % Expected life (in years) 5 5 Option activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Aggregate Intrinsic Value ($) Options outstanding at December 31, 2020 713,010 5.15 4.40 477,802 Granted 698,831 3.29 4.39 46,800 Exercised (5,204 ) 2.50 - - Forfeited or cancelled (10,755 ) 3.49 - - Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 162,000 2.50 4.69 - Exercised - - - - Forfeited or cancelled (29,245 ) 4.54 - - Options outstanding June 30, 2022 1,528,637 4.05 3.53 - Options expected to vest in the future as of June 30, 2022 436,963 3.26 3.88 - Options exercisable at June 30, 2022 1,091,674 4.37 3.39 - Options vested, exercisable, and options expected to vest at June 30, 2022 1,528,637 4.05 3.53 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price below the $ 1.28 1.28 At June 30, 2022, there was $ 990,838 1.77 Stock Appreciation Rights On June 23, 2020, the board of directors (the “Board”) of the Company adopted the Sigma Labs, Inc. 2020 Stock Appreciation Rights Plan (the “Plan”). The purposes of the Plan are to: (i) enable the Company to attract and retain the types of employees, consultants, and directors (collectively, “Service Providers”) who will contribute to the Company’s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the shareholders of the Company; and (iii) promote the success of the Company’s business. The Plan provides for incentive awards only in the form of stock appreciation rights payable in cash (“SARs”) and no shares of common stock are reserved or will be issued pursuant to the Plan. SARs may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company’s common stock (“Share”) upon the exercise of the SAR. The “Spread” is the difference between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a Share on the date of grant of the SAR. The administrator of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including, without limitation, the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant. On January 3, 2022, the Company granted a total of 12,033 1.87 On February 16, 2022, the Company granted 30,000 2.50 On March 31, 2022, the Company granted 3,000 2.50 The Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period for each SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 “Compensation-Stock Compensation”, and any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date. The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the six months ended June 30, 2022 and the year ended December 31, 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions Assumptions: 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.82 1.65 % 0.39 0.40 % Expected volatility 108.4 119.0 % 123.0 % Expected life (in years) 5 5 SARs activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Aggregate Intrinsic Value ($) - SARs outstanding at December 31, 2020 127,679 2.61 4.52 97,919 Granted 242,945 3.43 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 45,033 2.33 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding June 30, 2022 415,657 3.06 3.83 - SARs expected to vest in the future as of June 30, 2022 297,674 3.24 4.02 - SARs exercisable at June 30, 2022 117,983 2.62 3.37 - SARs vested, exercisable, and SARs expected to vest at June 30, 2022 415,657 3.06 3.83 - The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of our common stock for those awards that have an exercise price currently below the $ 1.28 No 1.28 At June 30, 2022, there was $ 577,981 2.0 Warrants Warrant activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Warranty Activity Warrants Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Warrants outstanding at December 31, 2020 1,881,429 7.57 4.16 Granted 2,602,143 4.36 1.63 Exercised (495,641 ) 2.59 4.13 Forfeited or cancelled - - - Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (162,150 ) 40.00 - Warrants outstanding at June 30, 2022 3,825,781 4.66 1.69

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 5 - Subsequent Events On July 1, 2022, our Board of Directors (the “Board”), based upon determinations and recommendations of the Compensation Committee of the Board, approved the Company’s 2022 executive compensation program. The program includes targeted cash incentive bonuses and long-term equity incentive awards to Jacob Brunsberg, our Chief Executive Officer, Frank Orzechowski, our Chief Financial Officer, Darren Beckett, our Chief Technology Officer, and Mark Ruport, our other named executive officer as of December 31, 2021, whom we collectively refer to as the “Participating Persons.” Also, on July 1, 2022, the Board, upon the recommendation of the Compensation Committee, adopted retention bonus and change in control plans for certain of the Participating Persons.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Nature of Business	Nature of Business
Basis of Presentation	Basis of Presentation
Reclassification	Reclassification
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company does not use derivative instruments for hedging of market risk or for trading or speculative purposes. On March 26, 2021, the Company issued warrants to purchase an aggregate of 2,190,000 May 24, 2021 12,000,000 24,000,000 May 24, 2023 Pursuant to ASC 815-40-25-10, because the Company did not have sufficient authorized and unissued shares of common stock available to settle the warrants at the issue date, such warrants were accounted for as a derivative liability. For the six months ended June 30, 2021, the Company recorded a gain of $ 1,092,441
Loss Per Share	Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share June 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,528,637 853,936 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,503,336 4,966,350 The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended June 30, 2022 and 2021: Schedule of Computing Loss Per Share 1 2 3 4 Three Months Ended June 30 Six Months Ended June 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.18 ) $ (0.43 ) $ (0.28 ) Loss Applicable to Common Stockholders (numerator) $ (2,261,390 ) $ (1,859,767 ) $ (4,483,005 ) $ (2,571,334 ) Weighted average number of common shares outstanding used in loss per share during the period (denominator) 10,498,802 10,493,598 10,498,802 9,149,328
Accounting Estimates	Accounting Estimates
Revenue Recognition	Revenue Recognition Revenue from Contracts with Customers In January 2022, the Company began offering a subscription option to its customers, pursuant to which it enters into agreements to lease its PrintRite3D platform for terms between 12 and 36 months and provide technical support and maintenance for the term of the arrangement, as well as installation and training. The Company has determined these are leases because they relate to discrete pieces of equipment that customers have the right to substantially all the economic benefit from and exclusive right to use during the term of the arrangement. These leases are classified as operating leases and the Company retains title to the underlying equipment. The agreements may be renewed for successive one-year terms unless notice is given by either party of its intent not to renew at least 30 days before the end of the lease term. For leases with 36-month terms, the lessee may terminate the agreement after the first 18 months with 30-days written notice. Some, but not all, of the arrangements provide for a lessee to purchase the asset at a stated amount that approximates fair value and are not reasonably certain to be exercised at the inception of the arrangement. There are no anticipated variable lease payments at the inception of the arrangement. There are two non-lease components in the arrangement that consist of technical support and maintenance, and installation and training. The Company has elected the single component practical expedient to combine the technical support and maintenance with the lease as they have the same pattern of transfer. The installation and training do not have the same pattern of transfer; therefore, this component is not eligible for the single component practical expedient. The consideration has been allocated on a relative fair value basis of the underlying lease and non-lease components. The Company has estimated the residual value of the leased assets based on the life of the underlying assets, the ability to refurbish and sell the assets, as well as the Company’s ability to componentize the hardware and utilize subassemblies in other products. Revenue from lease payments related to these operating leases for the three and six months ended June 30, 2022 was $ 14,138 20,138 Minimum Lease Payments Receivable Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 18,000 2023 $ 3,000 2024 - 2025 and thereafter - Total $ 21,000 Assets Underlying Operating Leases: Assets under operating leases are comprised of the following: Schedule of Assets underlying operating leases June 30, 2022 PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 2,782 Net Book Value $ 36,167 The Company is depreciating assets over their useful life of 7

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share June 30, 2022 2021 Warrants 3,825,781 3,987,931 Stock Options 1,528,637 853,936 Preferred Stock 148,918 124,483 Total Underlying Common Shares 5,503,336 4,966,350
Schedule of Computing Loss Per Share	The following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares of dilutive potential common stock for the periods ended June 30, 2022 and 2021: Schedule of Computing Loss Per Share 1 2 3 4 Three Months Ended June 30 Six Months Ended June 30 2022 2021 2022 2021 Net Loss per Common Share - Basic and Diluted $ (0.22 ) $ (0.18 ) $ (0.43 ) $ (0.28 ) Loss Applicable to Common Stockholders (numerator) $ (2,261,390 ) $ (1,859,767 ) $ (4,483,005 ) $ (2,571,334 ) Weighted average number of common shares outstanding used in loss per share during the period (denominator) 10,498,802 10,493,598 10,498,802 9,149,328
Schedule of Minimum Lease Payments Receivable	Minimum lease payments receivable for each of the succeeding years ending December 31 are as follows: Schedule of Minimum Lease Payments Receivable Year ending December 31, Amount 2022 (remaining) $ 18,000 2023 $ 3,000 2024 - 2025 and thereafter - Total $ 21,000
Schedule of Assets underlying operating leases	Assets under operating leases are comprised of the following: Schedule of Assets underlying operating leases June 30, 2022 PrintRite 3D Hardware $ 38,949 Accumulated Depreciation 2,782 Net Book Value $ 36,167

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	At June 30, 2022 and December 31, 2021, the Company’s inventory was comprised of: Schedule of Inventory June 30, 2022 December 31, 2021 Raw Materials $ 172,863 $ 202,015 Work in Process 328,720 224,079 Finished Goods 282,083 283,986 Total Inventory $ 783,666 $ 710,080

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	Schedule of Share Based Payments Award Stock Options Valuation Assumptions Assumptions: 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.95 1.65 % 0.19 0.32 % Expected volatility 106.4 110.0 % 116.8 123.8 % Expected life (in years) 5 5
Schedule of Stock Option Activity	Option activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Aggregate Intrinsic Value ($) Options outstanding at December 31, 2020 713,010 5.15 4.40 477,802 Granted 698,831 3.29 4.39 46,800 Exercised (5,204 ) 2.50 - - Forfeited or cancelled (10,755 ) 3.49 - - Options outstanding at December 31, 2021 1,395,882 4.24 3.89 - Granted 162,000 2.50 4.69 - Exercised - - - - Forfeited or cancelled (29,245 ) 4.54 - - Options outstanding June 30, 2022 1,528,637 4.05 3.53 - Options expected to vest in the future as of June 30, 2022 436,963 3.26 3.88 - Options exercisable at June 30, 2022 1,091,674 4.37 3.39 - Options vested, exercisable, and options expected to vest at June 30, 2022 1,528,637 4.05 3.53 -
Schedule of Warranty Activity	Warrant activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Warranty Activity Warrants Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Warrants outstanding at December 31, 2020 1,881,429 7.57 4.16 Granted 2,602,143 4.36 1.63 Exercised (495,641 ) 2.59 4.13 Forfeited or cancelled - - - Warrants outstanding at December 31, 2021 3,987,931 6.10 2.10 Granted - - - Exercised - - - Forfeited or cancelled (162,150 ) 40.00 - Warrants outstanding at June 30, 2022 3,825,781 4.66 1.69
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share Based Payments Award Stock Options Valuation Assumptions	The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the six months ended June 30, 2022 and the year ended December 31, 2021: Schedule of Share Based Payments Award Stock Options Valuation Assumptions Assumptions: 2022 2021 Dividend yield 0.00 % 0.00 % Risk-free interest rate 0.82 1.65 % 0.39 0.40 % Expected volatility 108.4 119.0 % 123.0 % Expected life (in years) 5 5
Schedule of Stock Option Activity	SARs activity for the six months ended June 30, 2022 and the year ended December 31, 2021 was as follows: Schedule of Stock Option Activity Options Weighted Average Exercise Price ($) Weighted Average Remaining Contractual Life (Yrs.) Aggregate Intrinsic Value ($) - SARs outstanding at December 31, 2020 127,679 2.61 4.52 97,919 Granted 242,945 3.43 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding at December 31, 2021 370,624 3.15 4.24 - Granted 45,033 2.33 4.61 - Exercised - - - - Forfeited or cancelled - - - - SARs outstanding June 30, 2022 415,657 3.06 3.83 - SARs expected to vest in the future as of June 30, 2022 297,674 3.24 4.02 - SARs exercisable at June 30, 2022 117,983 2.62 3.37 - SARs vested, exercisable, and SARs expected to vest at June 30, 2022 415,657 3.06 3.83 -

Schedule of Antidilutive Securi

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	5,503,336	4,966,350
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	3,825,781	3,987,931
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	1,528,637	853,936
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Underlying Common Shares	148,918	124,483

Schedule of Computing Loss Per

Schedule of Computing Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
Net Loss per Common Share - Basic and Diluted	$ (0.22)	$ (0.18)	$ (0.43)	$ (0.28)
Loss Applicable to Common Stockholders (numerator)	$ (2,261,390)	$ (1,859,767)	$ (4,483,005)	$ (2,571,334)
Weighted average number of common shares outstanding used in loss per share during the period (denominator)	10,498,802	10,493,598	10,498,802	9,149,328

Schedule of Minimum Lease Payme

Schedule of Minimum Lease Payments Receivable (Details)	Jun. 30, 2022 USD ($)
Accounting Policies [Abstract]
2022 (remaining)	$ 18,000
2023	3,000
2024
2025 and thereafter
Total	$ 21,000

Schedule of Assets underlying o

Schedule of Assets underlying operating leases (Details)	Jun. 30, 2022 USD ($)
Accounting Policies [Abstract]
PrintRite 3D Hardware	$ 38,949
Accumulated Depreciation	2,782
Net Book Value	$ 36,167

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Mar. 26, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Mar. 31, 2021	Mar. 25, 2021	Jan. 31, 2021
Accounting Policies [Abstract]
Aggregate warrant purchase of shares	2,190,000								136,943
Warrants exercisable date	May 24, 2021
Common shares authorized	24,000,000	24,000,000		24,000,000		24,000,000	12,000,000	12,000,000
Expiration date	May 24, 2023
Derivative liability			$ 290,156		$ 1,092,441
Lease income from operating leases		$ 14,138		$ 20,138
Asset useful life				7 years

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw Materials	$ 172,863	$ 202,015
Work in Process	328,720	224,079
Finished Goods	282,083	283,986
Total Inventory	$ 783,666	$ 710,080

Deferral of Social Security T_2

Deferral of Social Security Tax Payments (Details Narrative)	6 Months Ended
	Jun. 30, 2022 USD ($)
Deferral Of Social Security Tax Payments
Deferred Liabilities	$ 37,728
Tax credit carryforward, expiration ate	Dec. 31, 2022
Deferred tax, interest rate	0%

Schedule of Share Based Payment

Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield	0%	0%
Risk-free interest rate, minimum	0.95%	0.19%
Risk-free interest rate, maximum	1.65%	0.32%
Expected volatility, minimum	106.40%	116.80%
Expected volatility, maximum	110%	123.80%
Expected life	5 years	5 years
2020 Stock Appreciation Rights Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield	0%		0%
Risk-free interest rate, minimum	0.82%		0.39%
Risk-free interest rate, maximum	1.65%		0.40%
Expected volatility, minimum	108.40%
Expected volatility, maximum	119%
Expected life	5 years		5 years
Expected volatility			123%

Schedule of Stock Option Activi

Schedule of Stock Option Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	1,395,882	713,010
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 4.24	$ 5.15
Weighted Average Remaining Contractual Life, Outstanding Balance	3 years 6 months 10 days	3 years 10 months 20 days	4 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding Beginning Balance		$ 477,802
Number of Options, Granted	162,000	698,831
Weighted Average Exercise Price, Granted	$ 2.50	$ 3.29
Weighted Average Remaining Contractual Life, Granted	4 years 8 months 8 days	4 years 4 months 20 days
Aggregate Intrinsic Value, Granted		$ 46,800
Number of Options, Exercised		(5,204)
Weighted Average Exercise Price, Exercised		$ 2.50
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled	(29,245)	(10,755)
Weighted Average Exercise Price, Forfeited or cancelled	$ 4.54	$ 3.49
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding Ending Balance	1,528,637	1,395,882	713,010
Weighted Average Exercise Price, Outstanding Outstanding Balance	$ 4.05	$ 4.24	$ 5.15
Aggregate Intrinsic Value, Outstanding Outstanding Balance			$ 477,802
Number of Options, Expected to vest in the future Ending Balance	436,963
Weighted Average Exercise Price, Expected to Vest	$ 3.26
Weighted Average Remaining Contractual Life, Expected to Vest	3 years 10 months 17 days
Aggregate Intrinsic Value, Options expected to vest in the future
Number of Options, Exercisable	1,091,674
Weighted Average Exercise Price, Exercisable	$ 4.37
Weighted Average Remaining Contractual Life, Exercisable	3 years 4 months 20 days
Aggregate Intrinsic Value, Options exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	1,528,637
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 4.05
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	3 years 6 months 10 days
Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest
Number of Options, Exercised		5,204
Number of Options, Forfeited or cancelled	29,245	10,755
Stock Appreciation Rights [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	370,624	127,679
Weighted Average Exercise Price, Outstanding Beginning Balance	$ 3.15	$ 2.61
Weighted Average Remaining Contractual Life, Outstanding Balance	3 years 9 months 29 days	4 years 2 months 26 days	4 years 6 months 7 days
Aggregate Intrinsic Value, Outstanding Beginning Balance		$ 97,919
Number of Options, Granted	45,033	242,945
Weighted Average Remaining Contractual Life, Granted	4 years 7 months 9 days	4 years 7 months 9 days
Aggregate Intrinsic Value, Granted
Number of Options, Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Forfeited or cancelled
Aggregate Intrinsic Value, Forfeited or cancelled
Number of Options, Outstanding Ending Balance	415,657	370,624	127,679
Weighted Average Exercise Price, Outstanding Outstanding Balance	$ 3.06	$ 3.15	$ 2.61
Aggregate Intrinsic Value, Outstanding Outstanding Balance			$ 97,919
Number of Options, Expected to vest in the future Ending Balance	297,674
Weighted Average Exercise Price, Expected to Vest	$ 3.24
Weighted Average Remaining Contractual Life, Expected to Vest	4 years 7 days
Aggregate Intrinsic Value, Options expected to vest in the future
Number of Options, Exercisable	117,983
Weighted Average Exercise Price, Exercisable	$ 2.62
Weighted Average Remaining Contractual Life, Exercisable	3 years 4 months 13 days
Aggregate Intrinsic Value, Options exercisable
Number of Options, Vested, Exercisable and Options Expected to Vest Ending Balance	415,657
Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest	$ 3.06
Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest	3 years 9 months 29 days
Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest
Number of Options, Exercised
Number of Options, Forfeited or cancelled

Schedule of Warranty Activity (

Schedule of Warranty Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Warrants Outstanding, Beginning Balance	3,987,931	1,881,429
Weighted Average Exercise Price Outstanding, Beginning Balance	$ 6.10	$ 7.57
Weighted Average Remaining Contractual Life Years, Ending Balance	1 year 8 months 8 days	2 years 1 month 6 days	4 years 1 month 28 days
Warrants, Granted		2,602,143
Weighted Average Exercise Price Outstanding, Granted		$ 4.36
Weighted Average Remaining Contractual Life Years, Granted		1 year 7 months 17 days
Warrants,Exercised		(495,641)
Weighted Average Exercise Price Outstanding, Exercised		$ 2.59
Weighted Average Remaining Contractual Life Years, Exercised		4 years 1 month 17 days
Warrants, Forfeited or cancelled	162,150
Weighted Average Exercise Price Outstanding, Forfeited or cancelled	$ 40
Warrants,Exercised		495,641
Warrants, Forfeited or cancelled	(162,150)
Warrants Outstanding, Ending Balance	3,825,781	3,987,931	1,881,429
Weighted Average Exercise Price Outstanding,Ending Balance	$ 4.66	$ 6.10	$ 7.57

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative)					1 Months Ended							3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2022 $ / shares shares	Feb. 16, 2022 $ / shares shares	Jan. 03, 2022 $ / shares shares	Mar. 26, 2021 shares	Jun. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 $ / shares shares	Feb. 28, 2022 $ / shares shares	Mar. 31, 2021 USD ($) $ / shares shares	Feb. 28, 2021 shares	Jan. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2020 $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares shares	May 24, 2021 shares	Mar. 25, 2021 shares
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized				24,000,000	24,000,000			12,000,000				24,000,000		24,000,000		24,000,000		12,000,000
Common stock issued during period										1,711,783
Share price per share | $ / shares										$ 3
Proceeds from public offering | $										$ 4,532,445
Warrants to purchase shares of common stock				2,190,000						136,943
Warrant exercise price | $ / shares										$ 3.75
Number of shares, warrants exercised																495,641
Warrants exercisable date				May 24, 2021
Preferred stock, shares authorized					10,000,000							10,000,000		10,000,000		10,000,000
Preferred stock, par value | $ / shares					$ 0.001							$ 0.001		$ 0.001		$ 0.001
Preferred stock, shares issued					465							465		465		465
Preferred stock, shares outstanding					465							465		465		465
Number of shares granted														162,000		698,831
Allocation share based compensation expense | $												$ 167,439	$ 116,441	$ 338,415	$ 233,919
Options exercise price | $ / shares														$ 1.28
Stock options compensation cost | $					$ 990,838							$ 990,838		$ 990,838
Weighted average remaining recognition period														1 year 9 months 7 days
Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted						56,000
Option strike price | $ / shares	$ 2.50				$ 2.50	$ 2.50						$ 2.50		$ 2.50
Stock option grant percentage														50%
Stock option remaining grant percentage														50%
Four Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted														22,000
President and CEO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted							70,000
Option strike price | $ / shares							$ 2.50
Options exercise price | $ / shares		$ 2.50
Common shares granted for the period		30,000
Two Consultants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted						14,000
Option strike price | $ / shares	2.50					$ 2.50
Eleven Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price | $ / shares			$ 1.87
Common shares granted for the period			12,033
Consultant [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price | $ / shares	$ 2.50
Common shares granted for the period	3,000
2013 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock shares reserved for issuance					201,861							201,861		201,861
2020 Stock Appreciation Rights Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price | $ / shares														$ 1.28
Weighted average remaining recognition period														2 years
Number of shares granted														0
Unrecognized share based compensation cost | $					$ 577,981							$ 577,981		$ 577,981
Investor [Member]
Subsidiary, Sale of Stock [Line Items]
Share price per share | $ / shares								$ 4.99
Stock issued during the period, service rendered								1,500
April 2020 Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								21,591
Number of shares, warrants exercised								191,204
Placement Agent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price | $ / shares								$ 5.55625
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of warrant exercise price								1.25
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period															3,901,783
Stock issued during the period, service rendered															1,500
Common Stock [Member] | Placement Agent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock								175,200
Percentage of warrant exercise price								0.08
Common Stock [Member] | Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of warrant exercise price								8
Series D Convertible Preferred Stock [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock shares converted								250
Number of shares as in-kind payment, shares								19,000
Series D Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period					87,267
Preferred stock, shares outstanding					132							132		132
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value | $ / shares											$ 1,000
Sale of shares											1,640
Dividend percentage											9%
Conversion price per share | $ / shares											$ 2.50
Conversion description											Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed.
Series E Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period					61,651
Preferred stock, shares outstanding					333							333		333
Series E Preferred Stock [Member] | Other Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock shares converted					48,544
Preferred stock, par value | $ / shares					$ 1,000							$ 1,000		$ 1,000
Sale of shares					333
Dividend percentage					9%
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								119,000	263,200
Private Placement [Member] | Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock								2,190,000
Warrant exercise price | $ / shares								$ 4.32
Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								2,190,000
Share price per share | $ / shares								$ 4.445
Proceeds from public offering | $								$ 8,736,487
Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized																	12,000,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized																	24,000,000